Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$84.27

0.31 (0.37%)

12:44
03/20/17
03/20
12:44
03/20/17
12:44

Eli Lilly issues price transparency report, says net price rose 2.4% last year

Eli Lilly CEO Dave Ricks stated in a company blog post Monday: "Our discounts are now larger than ever. Lilly cut the average U.S. list price of our medicines by a full 50% last year via rebates and discounts. That's nearly twice as much as we did just five years ago - when the average discount was 28%. Because of these growing discounts, the average U.S. net price of Lilly medicines - the actual amount we recoup from selling our products - rose 2.4% last year. That's lower than overall medical inflation. Information about Lilly's list and net prices, and rebates and discounts, is now included in the '2016 Lilly Integrated Summary Report,' which we released today. We hope this greater level of transparency makes it easier for patients, physicians, policymakers, and others to understand our pricing." Reference Link

  • 20

    Mar

  • 22

    Mar

  • 19

    Apr

LLY Eli Lilly
$84.27

0.31 (0.37%)

03/20/17
UBSW
03/20/17
NO CHANGE
Target $85
UBSW
Neutral
Eli Lilly price target raised to $85 from $70 at UBS
UBS analyst Marc Goodman raised his price target on Eli Lilly to $85 from $70 as he updated his model to account for two months of IMS prescription data. Overall his 2017 revenues are largely unchanged but he raised his estimates slightly for 2018. Goodman also noted the positive upcoming data readouts are likely priced into the stock already. Goodman maintained a Neutral rating on Eli Lilly shares.
03/16/17
03/16/17
DOWNGRADE

Eli Lilly delines 2%, or $1.36, to $84.52
01/23/17
LEHM
01/23/17
DOWNGRADE
Target $45
LEHM
Equal Weight
CoLucid Pharmaceuticals downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Douglas Tsao downgraded CoLucid Pharmaceuticals (CLCD) to Equal Weight citing the takeover agreement by Eli Lilly (LLY). The analyst keeps a $45 price target for the shares.
01/19/17
SBSH
01/19/17
NO CHANGE
Target $100
SBSH
Buy
Eli Lilly story 'sharper' after solanezemab failure, says Citi
Citi analyst Andrew Baum believes Eli Lilly's (LLY) equity story has "become sharper" with the uncertainty of the failed solanezemab trial now removed. Recent and anticipated launches are set to drive an anticipated annual earnings growth rate of 13% over the next five years, Baum tells investors in a research note. He views the growth as attractive and continues to prefer Lilly and Bristol-Myers (BMY) among the U.S. major pharmaceutical names. The analyst lowered his price target for Lilly shares to $100 from $110 to reflect the failure in Alzheimer's and keeps a Buy rating on the name.

TODAY'S FREE FLY STORIES

SXI

Standex

$88.80

-0.05 (-0.06%)

10:40
05/23/17
05/23
10:40
05/23/17
10:40
Conference/Events
Standex management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBPX

Continental Building

$24.15

0.05 (0.21%)

10:39
05/23/17
05/23
10:39
05/23/17
10:39
Conference/Events
Continental Building management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MXIM

Maxim Integrated

$46.69

-0.16 (-0.34%)

10:38
05/23/17
05/23
10:38
05/23/17
10:38
Hot Stocks
Maxim Integrated anticipates strong cash flow growth »

All strategies are geared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

10:35
05/23/17
05/23
10:35
05/23/17
10:35
General news
The 11.4% April new home sales plunge »

The 11.4% April new home…

TARO

Taro Pharmaceutical

$108.86

-3.465 (-3.08%)

10:32
05/23/17
05/23
10:32
05/23/17
10:32
Downgrade
Taro Pharmaceutical rating change  »

Taro Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MXIM

Maxim Integrated

$46.69

-0.16 (-0.34%)

10:30
05/23/17
05/23
10:30
05/23/17
10:30
Hot Stocks
Maxim says has 'great' products for power management in industrial business »

The company sees factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

EWS

iShares MSCI Singapore Index

$23.77

-0.06 (-0.25%)

10:30
05/23/17
05/23
10:30
05/23/17
10:30
Options
Opening interest in iShares MSCI Singapore ETF options »

Opening interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLND

Talend

$31.85

-0.16 (-0.50%)

10:28
05/23/17
05/23
10:28
05/23/17
10:28
Conference/Events
Talend management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 13

    Jun

WYN

Wyndham

$96.72

0.73 (0.76%)

10:28
05/23/17
05/23
10:28
05/23/17
10:28
Conference/Events
Wyndham management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

SOHU

Sohu.com

$49.22

3.09 (6.70%)

10:27
05/23/17
05/23
10:27
05/23/17
10:27
Downgrade
Sohu.com rating change  »

Sohu.com downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHP

BHP Billiton

$36.45

-0.44 (-1.19%)

, BCS

Barclays

$11.10

-0.04 (-0.36%)

10:26
05/23/17
05/23
10:26
05/23/17
10:26
Periodicals
BHP hires Barclays to divest U.S. shale gas assets, Reuters reports »

BHP (BHP) has hired…

BHP

BHP Billiton

$36.45

-0.44 (-1.19%)

BCS

Barclays

$11.10

-0.04 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

TWOU

2U

$42.99

1 (2.38%)

10:26
05/23/17
05/23
10:26
05/23/17
10:26
Conference/Events
2U management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

STL

Sterling Bancorp

$21.75

-0.1 (-0.46%)

10:25
05/23/17
05/23
10:25
05/23/17
10:25
Conference/Events
Sterling Bancorp management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

LULU

lululemon

$49.51

0.22 (0.45%)

10:25
05/23/17
05/23
10:25
05/23/17
10:25
Hot Stocks
lululemon falls following website outages »

Shares of lululemon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

SAP

SAP

$106.14

0.4 (0.38%)

10:24
05/23/17
05/23
10:24
05/23/17
10:24
Conference/Events
SAP management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

MXIM

Maxim Integrated

$46.69

-0.16 (-0.34%)

10:24
05/23/17
05/23
10:24
05/23/17
10:24
Hot Stocks
Breaking Hot Stocks news story on Maxim Integrated »

Maxim Integrated sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

JNJ

Johnson & Johnson

$128.09

0.83 (0.65%)

10:23
05/23/17
05/23
10:23
05/23/17
10:23
Hot Stocks
Breaking Hot Stocks news story on Johnson & Johnson »

J&J CFO says creating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 06

    Jun

ONB

Old National Bancorp

$16.10

-0.05 (-0.31%)

10:22
05/23/17
05/23
10:22
05/23/17
10:22
Conference/Events
Old National Bancorp management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

  • 18

    Sep

MXIM

Maxim Integrated

$46.69

-0.16 (-0.34%)

, NVDA

Nvidia

$138.90

2.9 (2.13%)

10:22
05/23/17
05/23
10:22
05/23/17
10:22
Hot Stocks
Maxim says partnership with Nvidia 'works well,' no conflicts »

Also working with Nvidia…

MXIM

Maxim Integrated

$46.69

-0.16 (-0.34%)

NVDA

Nvidia

$138.90

2.9 (2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 01

    Jun

  • 09

    Jun

JNJ

Johnson & Johnson

$128.09

0.83 (0.65%)

10:21
05/23/17
05/23
10:21
05/23/17
10:21
Hot Stocks
Johnson & Johnson says wants to generate value for shareholders in any M&A deals »

Says looking at strategic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 06

    Jun

OFC

Corporate Office Properties

$33.66

0.08 (0.24%)

10:21
05/23/17
05/23
10:21
05/23/17
10:21
Conference/Events
Corporate Office Properties management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

ALXN

Alexion

$115.42

1.58 (1.39%)

10:21
05/23/17
05/23
10:21
05/23/17
10:21
Downgrade
Alexion rating change  »

Alexion downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CLDR

Cloudera

$21.32

0.41 (1.96%)

, EEX

Emerald Expositions Events

$21.93

-0.075 (-0.34%)

10:21
05/23/17
05/23
10:21
05/23/17
10:21
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

CLDR

Cloudera

$21.32

0.41 (1.96%)

EEX

Emerald Expositions Events

$21.93

-0.075 (-0.34%)

ZYME

Zymeworks

$13.00

-0.06 (-0.46%)

CVNA

Carvana

$11.20

0.1165 (1.05%)

JBHT

J.B. Hunt

$84.25

0.11 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 23

    May

  • 25

    May

  • 31

    May

  • 02

    Jun

  • 08

    Jun

AZO

AutoZone

$603.74

-55.75 (-8.45%)

, HP

Helmerich & Payne

$56.79

-3.09 (-5.16%)

10:21
05/23/17
05/23
10:21
05/23/17
10:21
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

AZO

AutoZone

$603.74

-55.75 (-8.45%)

HP

Helmerich & Payne

$56.79

-3.09 (-5.16%)

FRSH

Papa Murphy's

$5.04

0.03 (0.60%)

COLM

Columbia Sportswear

$53.17

0.51 (0.97%)

XLNX

Xilinx

$67.52

0.85 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 24

    May

  • 01

    Jun

  • 13

    Jun

MCK

McKesson

$158.56

3.14 (2.02%)

, AEGN

Aegion

$19.48

0.01 (0.05%)

10:21
05/23/17
05/23
10:21
05/23/17
10:21
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

MCK

McKesson

$158.56

3.14 (2.02%)

AEGN

Aegion

$19.48

0.01 (0.05%)

WING

Wingstop

$29.65

-0.53 (-1.76%)

PRXL

Parexel

$79.31

0.16 (0.20%)

ONDK

On Deck Capital

$3.77

0.14 (3.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 26

    May

  • 06

    Jun

  • 20

    Jun

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.